RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Gilead Sciences Inc.

A collection of news and information related to Gilead Sciences Inc. published by this site and its partners.

Top Gilead Sciences Inc. Articles

Displaying items 23-27
  • FDA approves Gilead's four-drug HIV treatment

    FDA approves Gilead's four-drug HIV treatment
    (Reuters) - U.S. health regulators on Monday approved Gilead Sciences Inc's four-drug combination pill to treat HIV, the virus that causes AIDS. The four drugs in one pill, which was formerly called the Quad and had been considered one of Gilead's more...
  • FDA approves drug to prevent HIV infection

    FDA approves drug to prevent HIV infection
    The federal government has approved for the first time a drug that can prevent an HIV infection, a significant development for Baltimore where transmission rates for the virus remain high and growing. The U.S. Food and Drug Administration approved...
  • AIDS deaths worldwide drop as access to drugs improves

    AIDS deaths worldwide drop as access to drugs improves
    LOS ANGELES/GENEVA (Reuters) - Fewer people infected with HIV globally are dying as more of them get access to crucial antiretroviral drugs, particularly in sub-Saharan Africa, the United Nations AIDS program said on Wednesday. The United Nations...
  • WHO endorses use of HIV medicines for prevention

    WHO endorses use of HIV medicines for prevention
    NEW YORK (Reuters) - The World Health Organization has endorsed using HIV medicines among people who do not have the infection but are at high risk of getting it and suggested that poor and wealthy countries alike set up pilot projects to better...
  • FDA seeks to ban Chicago HIV doctor from research

    FDA seeks to ban Chicago HIV doctor from research
    In a rare move, federal regulators are seeking to disqualify a prominent Chicago HIV doctor from future drug studies after they discovered his clinic committed one of the most grievous sins of medical research: submitting fictitious data in a drug trial....